Treatment with infliximab restores normal aquaporin 5 distribution in minor salivary glands of patients with Sjögren's syndrome

Arthritis Rheum. 2002 Aug;46(8):2249-51. doi: 10.1002/art.10440.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / pharmacology*
  • Antibodies, Monoclonal / therapeutic use
  • Antirheumatic Agents / pharmacology*
  • Antirheumatic Agents / therapeutic use
  • Aquaporin 5
  • Aquaporins / metabolism*
  • Biopsy
  • Cell Count
  • Humans
  • Image Processing, Computer-Assisted
  • Immunohistochemistry
  • Infliximab
  • Membrane Proteins*
  • Salivary Glands, Minor / drug effects
  • Salivary Glands, Minor / metabolism*
  • Sjogren's Syndrome / drug therapy
  • Sjogren's Syndrome / metabolism*
  • Sjogren's Syndrome / pathology
  • Tumor Necrosis Factor-alpha / pharmacology*
  • Tumor Necrosis Factor-alpha / therapeutic use

Substances

  • AQP5 protein, human
  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Aquaporin 5
  • Aquaporins
  • Membrane Proteins
  • Tumor Necrosis Factor-alpha
  • Infliximab